A drug to treat advanced prostate cancer should be given to patients on the NHS, a health watchdog has said.
Abirateron, marketed as Zytiga, can extend the lives of late-stage cancer sufferers by more than three months.
The National Institute for Health and Clinical Excellence (Nice) revised its recommendations after fresh information from manufacturer Janssen, and the new draft guidance was welcomed by experts.
More top news
Couple behind BFvsGF channel say they are taking a break after the pressure of constantly posting videos took a toll on their relationship.
The EgyptAir plane that crashed into the Mediterranean Sea did not swerve before disappearing off radar, according to Egyptian authorities.
Jose Mourinho is a step closer to being appointed the new Manchester United manager after Louis Van Gaal's turbulent reign was ended.